Evidence map›Paper›PMID 36506119›Full record

ArticleACS omega2022

Halogen Doping to Control the Band Gap of Ascorbic Acid: A Theoretical Study.

Ibrahim Isah Nasidi, Omer Kaygili, Abdul Majid, Niyazi Bulut, Mohammad Alkhedher, Sayed M ElDin

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Ibrahim Isah NasidiDepartment of Physics, Faculty of Science, Firat University, 23119 Elazig, Turkey.ORCID https://orcid.org/0000-0002-3983-4884
Omer KaygiliDepartment of Physics, Faculty of Science, Firat University, 23119 Elazig, Turkey.ORCID https://orcid.org/0000-0002-2321-1455
Abdul MajidDepartment of Physics, University of Gujrat, Gujrat 50700, Pakistan.ORCID https://orcid.org/0000-0003-0402-4838
Niyazi BulutDepartment of Physics, Faculty of Science, Firat University, 23119 Elazig, Turkey.ORCID https://orcid.org/0000-0003-2863-7700
Mohammad AlkhedherMechanical and Industrial Engineering Department, Abu Dhabi University, Abu Dhabi 111188, United Arab Emirates.
Sayed M ElDinCenter of Research, Faculty of Engineering & Technology, Future University in Egypt, New Cairo 11835, Egypt.
Fırat University · TRAbu Dhabi University · AEFuture University in Egypt · EGUniversity of Gujrat · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ascorbic acid is an important antioxidant agent that acts as an electron donor and is involved in many physiological processes. Structural modification in ascorbic acid is a subject of extensive biochemical research due to its involvement in a variety of relevant phenomena including electron transport, complex redox reactions, neurochemical reactions, enzymatic reactions, and chemotherapeutic potential. In this work, the structure of ascorbic acid is modified via doping with the first three members of the halogen group to investigate the changes in the electronic structure and spectroscopic parameters using first-principles methods. To obtain the lowest-energy structures, different basis sets in density functional theory (DFT) and Hartree-Fock approaches were employed in the geometry optimization process. The potential energy maps of the structures were computed to study the molecular orientations and their optical and electrical properties. The spectroscopic properties were computed via UV-vis and nuclear magnetic resonance (NMR) spectroscopies to study the effects of doping into the compound. To obtain further insights into the chemical structure, the Fourier transform infrared (FT-IR) spectra of the materials were theoretically investigated. It was found that the band gap is sensitive to doping as we moved from fluorine to chlorine and then to bromine.

Identifiers

PMID36506119
PMCPMC9730502
OpenAlexW4309729093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.